M
Margaret H. Collins
Researcher at Cincinnati Children's Hospital Medical Center
Publications - 270
Citations - 20269
Margaret H. Collins is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Eosinophilic esophagitis & Medicine. The author has an hindex of 67, co-authored 214 publications receiving 17134 citations. Previous affiliations of Margaret H. Collins include University of Cincinnati Academic Health Center & University of Cincinnati.
Papers
More filters
Journal ArticleDOI
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
Chris A. Liacouras,Glenn T. Furuta,Ikuo Hirano,Dan Atkins,Stephen Attwood,Peter A Bonis,A. Wesley Burks,Mirna Chehade,Margaret H. Collins,Evan S. Dellon,Ranjan Dohil,Gary W. Falk,Nirmala Gonsalves,Sandeep K. Gupta,David A. Katzka,Alfredo J. Lucendo,Jonathan E. Markowitz,Richard J. Noel,Robert D. Odze,Philip E. Putnam,Joel E. Richter,Yvonne Romero,Eduardo Ruchelli,Hugh A. Sampson,Alain M. Schoepfer,Nicholas J. Shaheen,Scott H. Sicherer,Stuart J. Spechler,Jonathan M. Spergel,Alex Straumann,Barry K. Wershil,Marc E. Rothenberg,Seema S. Aceves +32 more
TL;DR: A new conceptual definition is proposed highlighting that EoE represents a chronic, immune/antigen-mediated disease characterized clinically by symptoms related to esophageal dysfunction and histologically by eosinophil-predominant inflammation.
Journal ArticleDOI
Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.
Glenn T. Furuta,Chris A. Liacouras,Margaret H. Collins,Sandeep K. Gupta,Chris Justinich,Phil E. Putnam,Peter A Bonis,Eric Hassall,Alex Straumann,Marc E. Rothenberg +9 more
TL;DR: A multidisciplinary task force of 31 physicians assembled with the goal of determining diagnostic criteria and making recommendations for evaluation and treatment of children and adults with suspected eosinophilic esophagitis (EE) provided current recommendations for care of affected patients.
Journal ArticleDOI
Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis
Carine Blanchard,Ning Wang,Keith F. Stringer,Anil Mishra,Patricia C. Fulkerson,J. Pablo Abonia,Sean C. Jameson,Cassie L. Kirby,Michael R. Konikoff,Margaret H. Collins,Mitchell B. Cohen,Rachel Akers,Simon P. Hogan,Amal Assa'ad,Philip E. Putnam,Bruce J. Aronow,Marc E. Rothenberg +16 more
TL;DR: Eosinophilic esophagitis is an emerging disorder with a poorly understood pathogenesis and an empirical approach analyzing esophageal tissue by a genome-wide microarray expression analysis implicate eotaxin-3 as a critical effector molecule for EE and provide insight into disease pathogenesis.
Journal ArticleDOI
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.
Evan S. Dellon,Chris A. Liacouras,Javier Molina-Infante,Glenn T. Furuta,Jonathan M. Spergel,Noam Zevit,Stuart J. Spechler,Stephen Attwood,Alex Straumann,Seema S. Aceves,Jeffrey A. Alexander,Dan Atkins,Nicoleta C. Arva,Carine Blanchard,Peter A Bonis,Wendy Book,Kelley E. Capocelli,Mirna Chehade,Edaire Cheng,Margaret H. Collins,Carla M. Davis,Jorge Amil Dias,Carlo Di Lorenzo,Ranjan Dohil,Christophe Dupont,Gary W. Falk,Cristina Targa Ferreira,Adam T. Fox,Nirmala Gonsalves,Sandeep K. Gupta,David A. Katzka,Yoshikazu Kinoshita,Calies Menard-Katcher,Ellyn Kodroff,David C. Metz,Stephan Miehlke,Amanda B. Muir,Vincent A. Mukkada,Simon Murch,Samuel Nurko,Yoshikazu Ohtsuka,Rok Orel,Alexandra Papadopoulou,Kathryn A. Peterson,Hamish Philpott,Philip E. Putnam,Joel E. Richter,Rachel Rosen,Marc E. Rothenberg,Alain M. Schoepfer,Melissa Scott,Neil Shah,Javed Sheikh,Rhonda F. Souza,Mary Jo Strobel,Nicholas J. Talley,Michael F. Vaezi,Yvan Vandenplas,Mario C. Vieira,Marjorie M. Walker,Joshua B. Wechsler,Barry K. Wershil,Ting Wen,Guang Yu Yang,Ikuo Hirano,Albert J. Bredenoord +65 more
TL;DR: An updated diagnostic algorithm for EoE was developed, with removal of the PPI trial requirement, and the evidence suggests that PPIs are better classified as a treatment for esophageal eosinophilia that may be due to EOE than as a diagnostic criterion.
Journal ArticleDOI
A Randomized, Double-Blind, Placebo-Controlled Trial of Fluticasone Propionate for Pediatric Eosinophilic Esophagitis
Michael R. Konikoff,Richard J. Noel,Carine Blanchard,Cassie L. Kirby,Sean C. Jameson,Bridget K. Buckmeier,Rachel Akers,Mitchell B. Cohen,Margaret H. Collins,Amal Assa'ad,Seema S. Aceves,Philip E. Putnam,Marc E. Rothenberg +12 more
TL;DR: A randomized, double-blind, placebo-controlled trial of swallowed fluticasone propionate (FP) in the treatment of eosinophilic esophagitis was conducted by as mentioned in this paper.